Showing results (151-160 of 267) with videos related to

Sort By:
Pageof 27
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2007
Phase III trial of high-dose sequential chemotherapy with peripheral blood stem cell support compared with standard dose chemotherapy for first-line treatment of advanced ovarian cancer: intergroup trial of the AGO-Ovar/AIO and EBMTVolker Möbus, Hannes Wandt, Norbert Frickhofen, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|May 2, 2012
Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patientsSteffen Hahn, Jennifer Hecktor, Florian Grabellus, et al.
Clinical Chemistry and Laboratory Medicine|November 1, 2007
Altered angiogenesis in preeclampsia: evaluation of a new test system for measuring placental growth factorMarkus Schmidt, Canan Dogan, Cahid Birdir, et al.
Clinical Chemistry|November 12, 2013
Circulating U2 small nuclear RNA fragments as a novel diagnostic tool for patients with epithelial ovarian cancerJan Dominik Kuhlmann, Alexander Baraniskin, Stephan A Hahn, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|January 17, 2024
Impact of 2 years of COVID-19 pandemic on preterm birth: Experience from a tertiary center of obstetrics in western GermanyLaura E Nagel, Beatrix Reisch, Udo Schwenk, et al.
Genes, Chromosomes & Cancer|May 13, 2011
Loss of heterozygosity proximal to the M6P/IGF2R locus is predictive for the presence of disseminated tumor cells in the bone marrow of ovarian cancer patients before and after chemotherapyJan Dominik Kuhlmann, Heidi Schwarzenbach, Friedrich Otterbach, et al.
Journal of Cancer Research and Clinical Oncology|April 2, 2022
Programmed death receptor ligand-2 (PD-L2) bearing extracellular vesicles as a new biomarker to identify early triple-negative breast cancer patients at high risk for relapseOliver Hoffmann, Sebastian Wormland, Ann-Kathrin Bittner, et al.
Clinical Chemistry and Laboratory Medicine|February 22, 2007
Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndromeSusanne Hahn, Werner Kuehnel, Susanne Tan, et al.
Annals of Surgical Oncology|February 19, 2010
Influence of residual tumor on outcome in ovarian cancer patients with FIGO stage IV disease: an exploratory analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group)Pauline Wimberger, Michael Wehling, Nils Lehmann, et al.
Acta Radiologica (Stockholm, Sweden : 1987)|September 25, 2012
Comparison of the diagnostic value of FDG-PET/CT and axillary ultrasound for the detection of lymph node metastases in breast cancer patientsCarolin Riegger, Angela Koeninger, Verena Hartung, et al.
Pageof 27